These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 294308)

  • 1. Treatment of blast cell crisis of chronic myeloid leukemia with ICRF-159 (razoxane).
    Bakowski MT; Brearley RL; Wrigley PF
    Cancer Treat Rep; 1979; 63(11-12):2085-7. PubMed ID: 294308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited activity of ICRF-159 in advanced acute leukemia.
    Bakowski MT; Prentice HG; Lister TA; Malpas JS; McElwain TJ; Powles RL
    Cancer Treat Rep; 1979 Jan; 63(1):127-9. PubMed ID: 369684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.
    Benjamin RS; Keating MJ; Valdivieso M; McCredie KB; Livingston RA; Burgess MA; Rodriguez V; Bodey GP; Gottlieb JA
    Cancer Treat Rep; 1979 Jun; 63(6):939-43. PubMed ID: 380802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Razoxane in treatment of acute myeloid leukaemia.
    Bhavnani M; Dhir K; Delamore IW
    Br Med J; 1978 Sep; 2(6140):801. PubMed ID: 279388
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of vindesine in patients with acute leukemia.
    Sklaroff RB; Arlin Z; Young CW
    Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
    Brugarolas A; Buesa JM; Lacave AJ; Gracia Marco M; Valle Pereda M
    Cancer Clin Trials; 1978; 1(4):289-95. PubMed ID: 93030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
    Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Razoxane in treatment of acute myeloid leukaemia.
    Shaw D; Tudhope GR
    Br Med J; 1978 Oct; 2(6144):1089-90. PubMed ID: 280401
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
    Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
    Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
    Jehn U; Mezger J
    Cancer Treat Rep; 1985 Apr; 69(4):445-8. PubMed ID: 3857971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G; Weber G
    Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blast crisis in chronic myeloid leukemia. Results with vindesine and prednisolone].
    Nitsche D; Tschurtschenthaler G; Stöger M; Michlmayr G
    Dtsch Med Wochenschr; 1985 Dec; 110(50):1936-9. PubMed ID: 3865760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative observations in the treatment of acute leukaemia.
    Gráf F; Fekete S; Benedek S; Sréter L; Takácsi-Nagy L
    Haematologia (Budap); 1976; 10(1):81-7. PubMed ID: 1070470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy.
    Alimena G; Breccia M; Latagliata R; Carmosino I; Russo E; Biondo F; Diverio D; Mancini M; Nanni M; Mandelli F
    Cancer; 2006 Sep; 107(5):1008-13. PubMed ID: 16878324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.